Singular Health Financials
| SHG Stock | 0.24 0.01 4.00% |
Singular | Select Account or Indicator |
Please note, the imprecision that can be found in Singular Health's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Singular Health Group. Check Singular Health's Beneish M Score to see the likelihood of Singular Health's management manipulating its earnings.
Singular Health Stock Summary
Singular Health competes with Sports Entertainment, ARN Media, Southern Cross, and Skycity Entertainment. Singular Health is entity of Australia. It is traded as Stock on AU exchange.| Foreign Associate | USA |
Specialization | Health Care, Health Care Equipment & Services |
| Instrument | Australia Stock View All |
| Exchange | Australian Securities Exchange |
| ISIN | AU0000129892 |
| Business Address | 241 Discovery Drive, |
| Sector | Health Care Technology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | singular.health |
| Phone | 1300 167 975 |
You should never invest in Singular Health without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Singular Stock, because this is throwing your money away. Analyzing the key information contained in Singular Health's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Singular Health Key Financial Ratios
Singular Health's financial ratios allow both analysts and investors to convert raw data from Singular Health's financial statements into concise, actionable information that can be used to evaluate the performance of Singular Health over time and compare it to other companies across industries.| Revenue | 90.83 K | ||||
| Gross Profit | 318.96 K | ||||
| EBITDA | (2.89 M) | ||||
| Net Income | (2.88 M) | ||||
| Total Asset | 2.35 M |
Singular Health Key Balance Sheet Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Total Assets | 5.4M | 2.1M | 3.0M | 2.4M | 2.7M | 3.0M | |
| Other Current Liab | 146.8K | 185.2K | 258.5K | 635.9K | 731.3K | 767.9K | |
| Net Debt | (4.0M) | (1.1M) | 1.8M | (1.2M) | (1.4M) | (1.5M) | |
| Retained Earnings | (5.2M) | (11.1M) | (16.1M) | (20.9M) | (18.8M) | (17.9M) | |
| Accounts Payable | 50.7K | 120.6K | 161.0K | 50.7K | 58.3K | 105.2K | |
| Cash | 4.1M | 1.1M | 691.5K | 1.5M | 1.3M | 1.2M | |
| Net Receivables | 152.1K | 141.5K | 76.2K | 62.6K | 56.4K | 80.5K | |
| Other Current Assets | 9.2K | 29.3K | 86.4K | 683.3K | 785.8K | 825.1K | |
| Total Liab | 345.1K | 391.5K | 2.9M | 909.6K | 1.0M | 1.2M | |
| Total Current Assets | 4.3M | 1.3M | 983.4K | 2.2M | 2.5M | 2.0M | |
| Short Term Debt | 63.0K | 68.1K | 2.3M | 218.5K | 251.2K | 238.7K | |
| Intangible Assets | 637.9K | 454.5K | 1.0M | 113.7K | 130.8K | 124.2K |
Singular Health Key Income Statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Interest Income | 2.2K | 7.3K | 485.8K | 11.7K | 13.4K | 12.8K | |
| Interest Expense | 1.5M | 12.9K | 477.6K | 97.8K | 88.0K | 83.6K | |
| Total Revenue | 193.6K | 54.0K | 616.1K | 90.8K | 104.4K | 99.2K | |
| Gross Profit | (1.6M) | (2.1M) | (3.6M) | (2.7M) | (2.4M) | (2.5M) | |
| Operating Income | (3.0M) | (6.0M) | (5.1M) | (3.9M) | (3.5M) | (3.7M) | |
| Ebit | (3.0M) | (6.0M) | (4.9M) | (3.1M) | (2.8M) | (2.9M) | |
| Ebitda | (2.9M) | (5.7M) | (4.5M) | (2.9M) | (2.6M) | (2.7M) | |
| Cost Of Revenue | 1.8M | 2.2M | 4.2M | 2.8M | 3.2M | 2.6M | |
| Income Before Tax | (4.5M) | (6.0M) | (5.4M) | (2.9M) | (2.6M) | (2.7M) | |
| Net Income | (4.5M) | (6.0M) | (5.4M) | (4.9M) | (4.4M) | (4.7M) | |
| Income Tax Expense | 1.8M | 316.6K | 8.2K | 2.0M | 2.4M | 2.5M |
Singular Health Key Cash Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Investments | (300K) | (5.3K) | (626.9K) | (3.6K) | (4.1K) | (4.3K) | |
| Change In Cash | 4.0M | (3.0M) | (448.4K) | 763.7K | 687.4K | 721.7K | |
| Free Cash Flow | (2.2M) | (2.9M) | (2.5M) | (2.5M) | (2.3M) | (2.4M) | |
| Depreciation | 130.7K | 259.8K | 389.1K | 197.7K | 227.3K | 222.1K | |
| Other Non Cash Items | 2.3M | 3.2M | 2.8M | 599.0K | 688.9K | 654.4K | |
| Capital Expenditures | 310.6K | 11.8K | 22.5K | 73.6K | 66.2K | 108.4K | |
| Net Income | (4.5M) | (6.0M) | (5.4M) | (2.9M) | (2.6M) | (2.7M) | |
| End Period Cash Flow | 4.1M | 1.1M | 691.5K | 1.5M | 1.3M | 1.2M |
Singular Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Singular Health's current stock value. Our valuation model uses many indicators to compare Singular Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Singular Health competition to find correlations between indicators driving Singular Health's intrinsic value. More Info.Singular Health Group is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Singular Health's earnings, one of the primary drivers of an investment's value.Singular Health Group Systematic Risk
Singular Health's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Singular Health volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Singular Health Group correlated with the market. If Beta is less than 0 Singular Health generally moves in the opposite direction as compared to the market. If Singular Health Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Singular Health Group is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Singular Health is generally in the same direction as the market. If Beta > 1 Singular Health moves generally in the same direction as, but more than the movement of the benchmark.
Singular Health Group Total Assets Over Time
Singular Health Thematic Clasifications
Singular Health Group is part of several thematic ideas from Health Management to Management. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic IdeasSingular Health March 24, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Singular Health help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Singular Health Group. We use our internally-developed statistical techniques to arrive at the intrinsic value of Singular Health Group based on widely used predictive technical indicators. In general, we focus on analyzing Singular Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Singular Health's daily price indicators and compare them against related drivers.
| Downside Deviation | 8.54 | |||
| Information Ratio | 0.1136 | |||
| Maximum Drawdown | 29.29 | |||
| Value At Risk | (11.54) | |||
| Potential Upside | 12.0 |
Additional Tools for Singular Stock Analysis
When running Singular Health's price analysis, check to measure Singular Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Singular Health is operating at the current time. Most of Singular Health's value examination focuses on studying past and present price action to predict the probability of Singular Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Singular Health's price. Additionally, you may evaluate how the addition of Singular Health to your portfolios can decrease your overall portfolio volatility.